Guangzhou Shijian Cross-border E-commerce Co., Ltd – Trademark Portfolio

Entity Type: 99

Guangzhou Shijian Cross-border E-commerce Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SIVOLCARA. The owner is based in Guangzhou City, Guangdong Province.

M340, Room 1445

167 Linhe West Road, Tianhe District

Guangzhou City, Guangdong Province 510610 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SIVOLCARA
SIVOLCARA
Registered 2025

Trademark Classifications

Guangzhou Shijian Cross-border E-commerce Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Guangzhou Shijian Cross-border E-commerce Co., Ltd have?

Guangzhou Shijian Cross-border E-commerce Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangzhou Shijian Cross-border E-commerce Co., Ltd file in?

Guangzhou Shijian Cross-border E-commerce Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are Guangzhou Shijian Cross-border E-commerce Co., Ltd's most well-known trademarks?

Guangzhou Shijian Cross-border E-commerce Co., Ltd's registered trademark portfolio includes well-known marks such as SIVOLCARA. These are among 1 currently registered trademark in the portfolio.

What is Guangzhou Shijian Cross-border E-commerce Co., Ltd's trademark registration success rate?

Guangzhou Shijian Cross-border E-commerce Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.